-
Mashup Score: 7
OncLive® State of the Science Summit: Disease State, Month Day, Year. Oncology live event features research and clinical advances in oncology.
Source: event.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 02023 ESMO East | Total Health - 1 year(s) ago
Total Health’s 2023 ESMO Review will be a condensed review of the global meeting and will give healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care.
Source: www.totalhealthoncology.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0HOME - 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow® - 2 year(s) ago
At the 40th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics.
Source: event.gotoper.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
Our findings support the hypothesis that p16 has a similar prognostic role in both nonoropharyngeal and oropharyngeal cancer. Consideration should be given to increased testing for p16 in laryngeal, hypopharyngeal, and oral cavity primaries.
Source: PubMedCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas - PubMed - 3 year(s) ago
Patients with HPV-positive non-OPSCC exhibit similar characteristics as HPV-positive OPSCC. Overall survival was significantly higher for patients with HPV-positive versus HPV-negative non-OPSCC. These data reveal that HPV-positive non-OPSCC represent a favorable cohort that warrants recognition in …
Source: PubMedCategories: Latest Headlines, Oncologists2Tweet
Join us for OncLive/State of the Science Summit/Lung/Baltimore, MD/December 5, 2023 https://t.co/GiVwsMMxNa